CC
KDNY

Centiva Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Centiva Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61,734
Closed -$2.37M – 1720
2023
Q2 		$2.37M Buy
+61,734
New +$2.37M 0.05% 185